Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jacobson

Showing results (611-620 of 677) with videos related to

Pageof 68
Sort By:
Investigative Ophthalmology & Visual Science|February 28, 2007
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsTomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, et al.
Human Gene Therapy|May 17, 2020
Dose Range Finding Studies with Two <i>RPGR</i> Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene TherapyChunjuan Song, Valérie L Dufour, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|May 1, 2001
An analysis of allelic variation in the ABCA4 geneA R Webster, E Héon, A J Lotery, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vectorArtur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaJ Bennett, A M Maguire, A V Cideciyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of diseaseWilliam A Beltran, Artur V Cideciyan, Simone Iwabe, et al.
Human Gene Therapy|September 27, 2013
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapyArtur V Cideciyan, Robert B Hufnagel, Joseph Carroll, et al.
Human Molecular Genetics|May 9, 2008
Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanismSamuel G Jacobson, Artur V Cideciyan, Tomas S Aleman, et al.
Human Gene Therapy|December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosisSanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
American Journal of Human Genetics|October 27, 2009
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosaAlice E Davidson, Ian D Millar, Jill E Urquhart, et al.
Pageof 68

Showing results (611-620 of 677) with videos related to

Sort By:
Pageof 68
Investigative Ophthalmology & Visual Science|February 28, 2007
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsTomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, et al.
Human Gene Therapy|May 17, 2020
Dose Range Finding Studies with Two <i>RPGR</i> Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene TherapyChunjuan Song, Valérie L Dufour, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|May 1, 2001
An analysis of allelic variation in the ABCA4 geneA R Webster, E Héon, A J Lotery, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vectorArtur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retinaJ Bennett, A M Maguire, A V Cideciyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of diseaseWilliam A Beltran, Artur V Cideciyan, Simone Iwabe, et al.
Human Gene Therapy|September 27, 2013
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapyArtur V Cideciyan, Robert B Hufnagel, Joseph Carroll, et al.
Human Molecular Genetics|May 9, 2008
Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanismSamuel G Jacobson, Artur V Cideciyan, Tomas S Aleman, et al.
Human Gene Therapy|December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosisSanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
American Journal of Human Genetics|October 27, 2009
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosaAlice E Davidson, Ian D Millar, Jill E Urquhart, et al.
Pageof 68